ARCS Weekly Wrap 17 October 2025

In this week’s ARCS Weekly News Wrap, Tim Boyle returns from Adelaide after the KCA Conference to bring you the top stories shaping Australia’s life sciences sector. This episode covers: • Pharma: FDA approval for MSD’s subcutaneous Keytruda, Eli Lilly’s oral obesity drug heading to the TGA, and J&J’s Stelara patent challenge. • Medtech: AI-assisted diagnostics at Macquarie University and Optain Health’s new Melbourne research hub. • Biotech and Investment: Momentum from Clarity Pharmaceuticals, Telix, and Chimeric Therapeutics as local innovation continues to accelerate. • People Movement: Leadership changes across Novartis, Boehringer Ingelheim, and Boston Scientific. Tim also reminds listeners that early bird pricing for the ARCS Clinical Summit closes 20 October and that places are still available for the upcoming Pharmacovigilance Inspections course. Stay informed, stay connected, and join the conversation with ARCS Australia – the professional home for Australia’s medtech and pharmaceutical sector. #ARCSAus #Pharma #Medtech #Biotech #LifeSciences #ClinicalResearch #ARCSWeeklyNewsWrap